Ambrx Biopharma, Inc. is a clinical-stage biologics company, which engages in discovering and developing a novel class of engineered precision biologics (EPBs). Using its proprietary expanded genetic code technology platform, it allows incorporating synthetic amino acids (SAAs) into proteins within living cells. Its product pipeline includes ARX788, ARX517, and ARX305. The company was founded on August 11, 2023 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ambrx Biopharma Inc. market cap is $1.77B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ambrx Biopharma Inc. 52 week high is $28.15 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ambrx Biopharma Inc. 52 week low is $6.55 as of November 15, 2026.
Ambrx Biopharma Inc. stock price today is $28.00.
Ambrx Biopharma Inc. stock price yesterday was $27.98.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ambrx Biopharma Inc.'s P/E ratio is -13.86.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ambrx Biopharma Inc. P/B ratio is 6.9051.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ambrx Biopharma Inc. 50-day moving average is $27.26.
